|Rating : 4.83 /5||
Tuberculosis is a major health care problem in the developing world. According to the WHO, a total of 9,400,000 new cases were diagnosed throughout the world in 2010. 30% of these cases were diagnosed in Africa whereas 35% were detected in South East Asia. The disease resulted in 1,300,000 deaths in 2010. People with decreased immunity are particularly susceptible, especially those with HIV. Resistance to anti-tuberculosis treatment also adds to the problem.
Who should undergo screening for tuberculosis?
People at high risk of contacting tuberculosis are advised to undergo screening for the disease. These include:
People living or working in close contact with tuberculosis patients
HIV patients and other people with decreased immunity
People living in areas where tuberculosis is very common i.e. most countries in Africa, Asia, Latin America and the Caribbean, Eastern Europe, and Russia
People living under conditions where tuberculosis spreads easily e.g. prisons
Drug addicts who inject drugs
Which tests are used for screening for tuberculosis?
Tests used to screen persons for tuberculosis include the tuberculin skin test and the Interferon – Release Assays
Tuberculin Skin Test (TST): Tuberculin skin test is also called as the Mantoux test, Pirquet test or the PPD test. In this test, a small test dose is injected between the layers of the skin (intrdermally) and the area is marked. After 48 to 72 hours, the area is checked for any induration (hard swelling).
An induration of more than 10 mm indicates a positive test and is seen in patients exposed to the tuberculosis bacteria.
An induration of more than 5 mm may be considered positive in patients with HIV or low immunity.
False negative reactions occur in people with low immunity or with severe infection.
False positive reactions may occur in patients with prior BCG vaccination and patients with infections caused by non tubercular mycobacteria.
Interferon - Release Assays: These are blood tests used to detect tuberculosis. When the blood of patients is incubated with certain proteins of TB bacteria, the immune cells from the patient’s blood release a substance called interferon. This is detected during these tests. Tests that are commercially available include the QuantiFERON – TB Gold, QuantiFERON-TB Gold In-Tube test (QFT-GIT) and T.SPOT.TB test.
False positive reactions in patients with BCG vaccination or with infections caused by non tubercular mycobacteria are less likely to occur with these tests.
These tests require less frequent visits to the hospital and results are available within 24 hours.
They do not require measurement of skin induration, which could be highly subjective and lead to errors.
They are highly specific for tuberculosis. In addition, they do not boost responses to subsequent tests. These tests may not be preferred in children less than 5 years. They are also more expensive.
FAQs1. When should I call a doctor?
A consultation with your physician or tuberculosis specialist is advised if the results of the above tests come as abnormal.
2. What is meant by false positive and false negative test?
A false positive test means that the test has turned positive despite the patient not suffering from the disease. A false negative test means that the person suffers from the disease, yet the test has given a negative result.
3. Which of the above test is preferred?
The blood tests are preferred over the tuberculin test. However, they are expensive and may not be feasible to be carried out on a large number of people especially in the underdeveloped countries. They should also not be conducted in children less than 5 years.
4. My tuberculin test shows a red area but no induration. Is it positive?
No. Induration is necessary to read the test as positive.
A Taiwan scientist on Sunday unveiled what he said is the first low-cost and efficient test kit for identifying tuberculosis bacteria, killer of more than 1.5 million people worldwide every year.
The kit, which looks like those used for pregnancy tests, can establish whether samples taken from a suspected TB patient are positive or not in less than five minutes, the inventor said, following a seminar in Taipei held to mark World Tuberculosis Day.
"If used with the help of professionals, the accuracy of the test kit is around 98 percent," Professor Lai Hsin-chih, head of the Department of Medical Biotechnology and Laboratory Science at Taiwan's Chang Gung University, told AFP.
He put the accuracy of existing kits at around 50-60 percent, claiming that his is more accurate because it tests against "the unique nucleic acid of TB" rather than antibodies like existing tests.
"That's why our test kit is much more sensitive and accurate," he said.
Currently it takes eight weeks for hospital laboratories to obtain the results of patients' tests for the highly infectious disease.
"Compared with the traditional ways of testing TB patients, our test kit is much cheaper," Lai said.
"This is important as a great majority of TB patients are poor...hopefully the test kit would be a special help to them," he said, adding that the production cost of the kit is less than 50 Taiwan dollars (1.50 US).
Lai said he already has patent rights for the kit in Taiwan and has sought rights with the US authorities too.
Some 1.6 million people died of TB in 2006 according to statistics provided by the World Health Organisation. The disease claims about 800 lives in Taiwan each year.
Related Links on Screening Tests for Tuberculosis
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to other organs.
Pulmonary tuberculosis is caused by Mycobacterium tuberculosis.It primarily involves lungs and extend to other parts of the body.
What happens when you Breathe? Learn about Respiratory System and process of respiration
News on Screening Tests for Tuberculosis